ConductScience.org, home

Paper42958331PubMed

Effects of selenium supplementation on glycemic indices and oxidative-stress biomarkers in adults: a systematic review, meta-analysis, and dose-response analysis of randomized controlled trials.

Yang XY and 7 others. Nutr J, 2026.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Effects of selenium supplementation on glycemic indices and oxidative-stress biomarkers in adults: a systematic review, meta-analysis, and dose-response analysis of randomized controlled trials. Papers, record 42958331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42958331

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effects of selenium supplementation on glycemic indices and oxidative-stress biomarkers in adults: a systematic review, meta-analysis, and dose-response analysis of randomized controlled trials.
Journal
Nutr J
Year
2026
Publication types
Journal Article, Meta-Analysis, Systematic Review
Revised in PubMed
2026-11-02

Source PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yang XYXin-Yue
2Xu PPan
3Tan XXin
4Sun YTYu-Ting
5Tang MMin
6Zhang CChao
7Wang LLong
8Wu SSShi-Shi

Source PubMed

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Dietary SupplementsMajor topic
Glycemic IndexMajor topic
Oxidative StressMajor topic
SeleniumMajor topic
Adult
Female
Humans
Pregnancy
Antioxidants
Biomarkers
Blood Glucose
Dose-Response Relationship, Drug
Glycated Hemoglobin
Insulin
Insulin Resistance
Randomized Controlled Trials as Topic

Source PubMed

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
X202110929025Innovation and Entrepreneurship Training ProgramPubMed
24Y064Shiyan City Scientific Research ProjectPubMed

Source PubMed

References54

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
140,227,249Selenium as an Antioxidant: Roles and Clinical Applications in Critically Ill and Trauma Patients: A Narrative Review.Antioxidants (Basel)2025https://conductscience.org/library/papers/40227249PubMed
223,633,679A randomized, placebo-controlled trial of selenium supplementation in patients with type 2 diabetes: effects on glucose homeostasis, oxidative stress, and lipid profile.Am J Ther2014https://conductscience.org/library/papers/23633679PubMed
331,667,685Effects of Selenium Supplementation on Asymmetric Dimethylarginine and Cardiometabolic Risk Factors in Patients with Polycystic Ovary Syndrome.Biol Trace Elem Res2020https://conductscience.org/library/papers/31667685PubMed
430,642,737Probiotic and selenium co-supplementation, and the effects on clinical, metabolic and genetic status in Alzheimer's disease: A randomized, double-blind, controlled trial.Clin Nutr2019https://conductscience.org/library/papers/30642737PubMed
542,087,966Scientific Opinion on Dietary Reference Values for selenium.EFSA J2014https://conductscience.org/library/papers/42087966PubMed
629,441,149Supplementation of Micronutrient Selenium in Metabolic Diseases: Its Role as an Antioxidant.Oxid Med Cell Longev2017https://conductscience.org/library/papers/29441149PubMed
733,650,299Effect of selenium on thyroid autoimmunity and regulatory T cells in patients with Hashimoto's thyroiditis: A prospective randomized-controlled trial.Clin Transl Sci2021https://conductscience.org/library/papers/33650299PubMed
823,387,439Cardiovascular disease and glycemic control in type 2 diabetes: now that the dust is settling from large clinical trials.Ann N Y Acad Sci2013https://conductscience.org/library/papers/23387439PubMed
920,182,627Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis.Mediators Inflamm2010https://conductscience.org/library/papers/20182627PubMed
1032,156,524Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease.Free Radic Biol Med2020https://conductscience.org/library/papers/32156524PubMed
1135,047,136Effects of sodium selenite and selenium-enriched yeast on cardiometabolic indices of patients with atherosclerosis: A double-blind randomized clinical trial study.J Cardiovasc Thorac Res2021https://conductscience.org/library/papers/35047136PubMed
1219,683,471Cellular mechanisms of insulin resistance: role of stress-regulated serine kinases and insulin receptor substrates (IRS) serine phosphorylation.Curr Opin Pharmacol2009https://conductscience.org/library/papers/19683471PubMed
1326,267,328Selenium Supplementation and the Effects on Reproductive Outcomes, Biomarkers of Inflammation, and Oxidative Stress in Women with Polycystic Ovary Syndrome.Horm Metab Res2016https://conductscience.org/library/papers/26267328PubMed
1425,758,370Effects of Zinc and Selenium Supplementation on Thyroid Function in Overweight and Obese Hypothyroid Female Patients: A Randomized Double-Blind Controlled Trial.J Am Coll Nutr2015https://conductscience.org/library/papers/25758370PubMed
1535,057,488Low-Glycemic Index Diets as an Intervention in Metabolic Diseases: A Systematic Review and Meta-Analysis.Nutrients2022https://conductscience.org/library/papers/35057488PubMed
1630,637,662Effects of Selenium Supplementation on Metabolic Status in Patients Undergoing for Coronary Artery Bypass Grafting (CABG) Surgery: a Randomized, Double-Blind, Placebo-Controlled Trial.Biol Trace Elem Res2019https://conductscience.org/library/papers/30637662PubMed
1725,510,442Metabolic response to selenium supplementation in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.Clin Endocrinol (Oxf)2015https://conductscience.org/library/papers/25510442PubMed
1827,647,263The effects of selenium supplementation on biomarkers of inflammation and oxidative stress in patients with diabetic nephropathy: a randomised, double-blind, placebo-controlled trial.Br J Nutr2016https://conductscience.org/library/papers/27647263PubMed
1935,706,870Effect of Selenium on Triglyceride and Total Cholesterol, Weight Gain, and Physical Activity on Hemodialysis Patients: A Randomized Double-Blinded Controlled Trial.Int J Prev Med2022https://conductscience.org/library/papers/35706870PubMed
2027,329,332A systematic review and meta-analysis of randomized controlled trials on the effects of magnesium supplementation on insulin sensitivity and glucose control.Pharmacol Res2016https://conductscience.org/library/papers/27329332PubMed

See all 54 references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42958331

GET https://conductscience.org/api/papers/v1/42958331/references?page=2